UK markets closed

Tryp Therapeutics Inc. (TRYPF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0562+0.0137 (+32.24%)
At close: 03:17PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.20M
Enterprise value 6.34M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)9.14
Enterprise value/revenue N/A
Enterprise value/EBITDA -1.56

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 39.34%
S&P500 52-week change 322.38%
52-week high 30.0919
52-week low 30.0041
50-day moving average 30.0248
200-day moving average 30.0385

Share statistics

Avg vol (3-month) 345.88k
Avg vol (10-day) 376.12k
Shares outstanding 596.42M
Implied shares outstanding 699.59M
Float 8154.01M
% held by insiders 10.70%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 31 Aug 2023
Most-recent quarter (mrq)29 Feb 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-55.90%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-2.95M
Diluted EPS (ttm)-0.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.26M
Total cash per share (mrq)0
Total debt (mrq)15.92M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.08
Book value per share (mrq)-0.06

Cash flow statement

Operating cash flow (ttm)-6.22M
Levered free cash flow (ttm)46.21k